5/15
08:30 am
veru
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
Low
Report
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
5/14
08:30 am
veru
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
Medium
Report
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
5/14
08:07 am
veru
Veru Inc. (NASDAQ: VERU) is now covered by analysts at B. Riley. They set a "buy" rating and a $5.00 price target on the stock.
Medium
Report
Veru Inc. (NASDAQ: VERU) is now covered by analysts at B. Riley. They set a "buy" rating and a $5.00 price target on the stock.
5/13
08:09 am
veru
Veru Inc. (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
Veru Inc. (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
5/8
06:34 am
veru
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program [Yahoo! Finance]
High
Report
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program [Yahoo! Finance]
5/8
06:30 am
veru
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
High
Report
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
5/6
08:06 am
veru
Veru Inc. (NASDAQ: VERU) had its price target raised by analysts at HC Wainwright from $2.00 to $3.00. They now have a "buy" rating on the stock.
Low
Report
Veru Inc. (NASDAQ: VERU) had its price target raised by analysts at HC Wainwright from $2.00 to $3.00. They now have a "buy" rating on the stock.
5/2
08:30 am
veru
Veru to Present at the GLP-1 Based Therapeutics Summit
Medium
Report
Veru to Present at the GLP-1 Based Therapeutics Summit
5/8/2024
06:30 am
veru
veru inc.
MISS
Report
-12.3%
veru inc.
8/10/2023
06:30 am
veru
veru inc.
BEAT
Report
-0.9%
veru inc.
Oppenheimer Holdings Inc.
5/17
07:46 pm
veru
Form 4 VERU INC. For: May 15 Filed by: FISCH HARRY
Neutral
Report
Form 4 VERU INC. For: May 15 Filed by: FISCH HARRY
5/17
07:42 pm
veru
Form 4 VERU INC. For: May 15 Filed by: STEINER MITCHELL SHUSTER
Neutral
Report
Form 4 VERU INC. For: May 15 Filed by: STEINER MITCHELL SHUSTER
5/9
04:11 pm
veru
Form 4 VERU INC. For: May 07 Filed by: Greco Michele
Low
Report
Form 4 VERU INC. For: May 07 Filed by: Greco Michele
5/9
04:02 pm
veru
Form 4 VERU INC. For: May 07 Filed by: BARNETTE K GARY
Low
Report
Form 4 VERU INC. For: May 07 Filed by: BARNETTE K GARY
5/9
03:52 pm
veru
Form 4 VERU INC. For: May 07 Filed by: FISCH HARRY
Medium
Report
Form 4 VERU INC. For: May 07 Filed by: FISCH HARRY
5/9
03:41 pm
veru
Form 4 VERU INC. For: May 07 Filed by: STEINER MITCHELL SHUSTER
Medium
Report
Form 4 VERU INC. For: May 07 Filed by: STEINER MITCHELL SHUSTER
5/9
01:07 pm
veru
Form DEFA14A VERU INC.
Low
Report
Form DEFA14A VERU INC.
5/9
01:03 pm
veru
Form DEFR14A VERU INC.
Low
Report
Form DEFR14A VERU INC.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register